Explore evidence

80.8 %The Xpert Ultra assay yielded an overall combination of sensitivity and specificity of 80.8% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobserved 2022-2023published 2024PloS onePubMeddocument of 7 observations

140,000 casesIn Kenya, 140000 new tuberculosis cases occurred in 2019.

Kenyatuberculoseobserved 2019published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 10 observations

80 %80% of patients assessed for antiretroviral therapy (ART) initiation presented with ≥1 tuberculosis (TB) symptoms.

Kenyatuberculosepublished 2020BMJ openPubMeddocument of 12 observations

61.9 %GeneXpert sensitivity in retreatment cases was 61.9%, compared to 42.9% for ZN microscopy and 47.6% for LED fluorescent microscopy.

Kenyatuberculoseobserved 2013-2014published 2019African Journal of Health SciencesOpenAlexdocument of 6 observations

46.7 %The pooled prevalence of abnormal lung function among individuals who completed treatment for pulmonary TB in low- and middle-income countries was 46.7%.

Kenyaabnormal lung function · post-TB lung disease · tuberculosepublished 2022PLOS global public healtheurope_pmcdocument of 11 observationsDOI 10.1371/journal.pgph.0000805

3.4 aORPatients with TB symptoms were over three times as likely to have a new HIV diagnosis in private not-for-profit facilities compared to those in government facilities (adjusted odds ratio (aOR) 3.40; 95% CI = 1.96–5.90).

Kenyatuberculose · VIH/sidaobserved 2018published 2022International journal of STD & AIDSPubMeddocument of 4 observations

0.4 %Among HIV-positive tuberculosis patients in Western Kenya, INH + ETO polyresistant strains occurred in 0.4% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

32.2 per_1000_person_monthsThe overall tuberculosis mortality rate was 32.2 deaths per 1000 person months in Vihiga County.

Kenyatuberculosepublished 2023African health sciencesPubMeddocument of 6 observations

85.7 %GeneXpert detected Mycobacterium tuberculosis with a sensitivity of 85.7% (95% CI: 67.4–100%) in muco-purulent sputum specimens.

Kenyatuberculosepublished 2014African Journal of Health SciencesOpenAlexdocument of 13 observations

72 %The specificity of C-reactive protein ≥3.3 mg/L for identifying pulmonary tuberculosis was 72% among people living with HIV receiving antiretroviral therapy in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

14.8 %Other yeasts were isolated from 13 out of 88 fungal-positive sputum samples (14.8%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

1 %Among HIV-negative tuberculosis patients in Western Kenya, ETH + ETO polyresistant strains occurred in 1.0% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

0.31 per_100000In 2015, there were 129 Xpert® sites in Kenya, with a mean Xpert® site density of 0.31 per 100,000 inhabitants.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

0.7 %Among HIV-negative tuberculosis patients in Western Kenya, INH + AMK polyresistant strains occurred in 0.7% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

4.3 %The prevalence of pulmonary tuberculosis was 4.3% among IPT-naïve people living with HIV in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

9.1 %Aspergillus niger was isolated from 8 out of 88 fungal-positive sputum samples (9.1%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

6,472 patients6472 (50%) of the included TB patients were clinically diagnosed.

Kenyatuberculoseobserved 2012 to 2018published 2021Scientific reportsPubMeddocument of 12 observations

EDCTP funds clinical trial interventions to fight HIV/AIDS, malaria, and tuberculosis in the sub-Saharan African region.

Kenyapaludisme · tuberculose · VIH/sidapublished 2009BMC public healtheurope_pmcdocument of 4 observationsDOI 10.1186/1471-2458-9-249

83 %Treatment success was 83% amongst bacteriologically confirmed TB patients.

Kenyatuberculosepublished 2021Scientific reportsPubMeddocument of 12 observations

68.9 %Among PLHIV enrolled into ART in Kenya between July 2015 and June 2018, 95,431 (68.9%) were initiated on isoniazid preventive therapy (IPT).

Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

67 isolatesIn Western Kenya, the LAM lineage accounted for 67 isolates (12.1%) of Mycobacterium tuberculosis.

Kenyatuberculosepublished 2023BMC pulmonary medicinePubMeddocument of 5 observations

33.4 CqAmong participants with tuberculosis, mean oral swab threshold quantitation cycle value was 33.4 at subsequent morning visit.

Kenyatuberculosepublished 2022PloS onePubMeddocument of 10 observations

10.6 %Mtb infection prevalence at 12-month follow-up was 10.6% among 265 HEU infants.

Kenyatuberculosepublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 10 observations

0.84 per_100_person_yearsThe incidence rate of pulmonary tuberculosis following IPT completion was 0.84 per 100 person-years among people living with HIV in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

12 isolatesIn Western Kenya, 12 (2.0%) Mycobacterium tuberculosis isolates were orphaned strains.

Kenyatuberculosepublished 2023BMC pulmonary medicinePubMeddocument of 5 observations